{"database": "openregs", "table": "dockets", "rows": [["FDA-2026-P-12447", "FDA", "Request that the FDA order manufacturers of all approved systemic fluroquinolone antibiotics (including ciprofloxacin, lavofloxacin, moxifloxacin, delafloxacin, and ofloxacin) to update their professional physician labeling and patient Medication Guides to achieve the following", "Nonrulemaking", "2026-10-15T15:31:45Z", "0b000064b966dbee", null, null, null, null, null, null, null, null, null, null, "list_pull"]], "columns": ["id", "agency_id", "title", "docket_type", "last_modified", "object_id", "rin", "dkabstract", "category", "subtype", "keywords", "program", "short_title", "effective_date", "organization", "attrs_raw", "attr_source"], "primary_keys": ["id"], "primary_key_values": ["FDA-2026-P-12447"], "units": {}, "query_ms": 0.2477859379723668, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}